Total synthesis and evaluation of [18F]MHMZ

Matthias M Herth, Fabian Debus, Markus Piel, Mikael Palner, Gitte M Knudsen, Hartmut Lüddens, Frank Rösch

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Radiochemical labeling of MDL 105725 using the secondary labeling precursor 2-[(18)F]fluoroethyltosylate ([(18)F]FETos) was carried out in yields of approximately 90% synthesizing [(18)F]MHMZ in a specific activity of approximately 50MBq/nmol with a starting activity of approximately 3GBq. Overall radiochemical yield including [(18)F]FETos synthon synthesis, [(18)F]fluoroalkylation and preparing the injectable [(18)F]MHMZ solution was 42% within a synthesis time of approximately 100 min. The novel compound showed excellent specific binding to the 5-HT(2A) receptor (K(i)=9.0 nM) in vitro and promising in vivo characteristics.

Original languageEnglish
JournalBioorganic & Medicinal Chemistry Letters
Volume18
Issue number4
Pages (from-to)1515-1519
ISSN0960-894X
DOIs
Publication statusPublished - 15. Feb 2008
Externally publishedYes

Keywords

  • Animals
  • Binding, Competitive
  • Brain/diagnostic imaging
  • Fluorine Radioisotopes/chemistry
  • Fluorobenzenes/chemical synthesis
  • Isotope Labeling
  • Ketanserin/analogs & derivatives
  • Kinetics
  • Piperidines/chemical synthesis
  • Radioligand Assay
  • Radionuclide Imaging
  • Radiopharmaceuticals/chemical synthesis
  • Rats
  • Receptor, Serotonin, 5-HT2A/metabolism
  • Serotonin 5-HT2 Receptor Antagonists
  • Serotonin Antagonists/chemical synthesis

Fingerprint

Dive into the research topics of 'Total synthesis and evaluation of [18F]MHMZ'. Together they form a unique fingerprint.

Cite this